Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118682882 | 11868288 | 2 | F | 20160826 | 20151224 | 20160826 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-10348563 | BRISTOL MYERS SQUIBB | 0.00 | N | F | Y | 3.03000 | KG | 20160826 | OT | US | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118682882 | 11868288 | 1 | PS | ZERIT | STAVUDINE | 1 | Transplacental | UNK | U | 20412 | CAPSULE, HARD | ||||||||
| 118682882 | 11868288 | 2 | SS | ZERIT | STAVUDINE | 1 | Oral | UNK | U | 20412 | |||||||||
| 118682882 | 11868288 | 3 | SS | EPIVIR | LAMIVUDINE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118682882 | 11868288 | 4 | SS | VIRACEPT | NELFINAVIR MESYLATE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118682882 | 11868288 | 5 | SS | ZIAGEN | ABACAVIR SULFATE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118682882 | 11868288 | 6 | C | SALBUMOL | ALBUTEROL SULFATE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118682882 | 11868288 | 7 | C | I RON | FERROUS FUMARATE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118682882 | 11868288 | 8 | C | MAGNE-B6 | MAGNESIUM LACTATEPYRIDOXINE HYDROCHLORIDE | 1 | Transplacental | UNK | U | 0 | |||||||||
| 118682882 | 11868288 | 9 | C | VITAMINS | VITAMINS | 1 | Transplacental | EXPOSURE DURING GESTATION. | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118682882 | 11868288 | 1 | Product used for unknown indication |
| 118682882 | 11868288 | 2 | Prophylaxis against HIV infection |
| 118682882 | 11868288 | 3 | Product used for unknown indication |
| 118682882 | 11868288 | 4 | Product used for unknown indication |
| 118682882 | 11868288 | 5 | Product used for unknown indication |
| 118682882 | 11868288 | 6 | Product used for unknown indication |
| 118682882 | 11868288 | 7 | Product used for unknown indication |
| 118682882 | 11868288 | 8 | Product used for unknown indication |
| 118682882 | 11868288 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118682882 | 11868288 | HO |
| 118682882 | 11868288 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118682882 | 11868288 | Anaemia | |
| 118682882 | 11868288 | Blood creatine phosphokinase increased | |
| 118682882 | 11868288 | Blood lactic acid increased | |
| 118682882 | 11868288 | Cholinergic syndrome | |
| 118682882 | 11868288 | Foetal exposure during pregnancy | |
| 118682882 | 11868288 | Gastrooesophageal reflux disease | |
| 118682882 | 11868288 | Hypertriglyceridaemia | |
| 118682882 | 11868288 | Malaise | |
| 118682882 | 11868288 | Mean cell volume increased | |
| 118682882 | 11868288 | Neutropenia | |
| 118682882 | 11868288 | Platelet count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |